News & Insights

News & Insights

News & Insights

News & Insights

Why CRWF is Critical

Share on Twitter Share on Facebook Share on LinkedIn Share via Email Share via SMS
April 17, 2020
Why CRWF is Critical
As we navigate through the impacts of COVID-19, CRWF is dedicated to remaining open for business and continuing to facilitate all existing protocols. While we remain focused on our current research protocols, our teams are gearing up for when study holds are lifted and we can start enrolling new patients.

Since we operate multiple dedicated research sites and remain fully staffed, we will be able to get new and delayed studies up and running quickly and efficiently.

Vaccines are on the forefront in the fight against the COVID-19, and CRWF is a research site capable of conducting those vaccine studies that pharmaceutical companies are finding to be essential. Our capabilities include:

1) Historical vaccine experience and successful enrollment track record

2) Rapid study start-up

3) Subject safety and data integrity

4) Database with over 10,000 patients

5) Phase I Unit capabilities

6) Virtual Trial Capable

If you would like to learn more about CRWF’s vaccine capabilities and future partnership opportunities, please reach out to: Barbara Keskiner at (813) 870-1292